These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36382186)

  • 1. Identification of a novel class of cyclic penta-peptides against hepatitis C virus as p7 channel blockers.
    Wei S; Liu C; Du L; Wu B; Zhong J; Tong Y; Wang S; OuYang B
    Comput Struct Biotechnol J; 2022; 20():5902-5910. PubMed ID: 36382186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor Development against p7 Channel in Hepatitis C Virus.
    Wei S; Hu X; Du L; Zhao L; Xue H; Liu C; Chou JJ; Zhong J; Tong Y; Wang S; OuYang B
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33802584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
    Mathew S; Fatima K; Fatmi MQ; Archunan G; Ilyas M; Begum N; Azhar E; Damanhouri G; Qadri I
    PLoS One; 2015; 10(6):e0126510. PubMed ID: 26030803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin.
    Madan V; Bartenschlager R
    Viruses; 2015 Aug; 7(8):4461-81. PubMed ID: 26258788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release.
    Foster TL; Thompson GS; Kalverda AP; Kankanala J; Bentham M; Wetherill LF; Thompson J; Barker AM; Clarke D; Noerenberg M; Pearson AR; Rowlands DJ; Homans SW; Harris M; Foster R; Griffin S
    Hepatology; 2014 Feb; 59(2):408-22. PubMed ID: 24022996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus p7-a viroporin crucial for virus assembly and an emerging target for antiviral therapy.
    Steinmann E; Pietschmann T
    Viruses; 2010 Sep; 2(9):2078-2095. PubMed ID: 21994720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the inhibitory mechanism of BIT225 drug against p7 viroporin using computational study.
    Behmard E; Abdolmaleki P; Taghdir M
    Biophys Chem; 2018 Feb; 233():47-54. PubMed ID: 29169687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual architecture of the p7 channel from hepatitis C virus.
    OuYang B; Xie S; Berardi MJ; Zhao X; Dev J; Yu W; Sun B; Chou JJ
    Nature; 2013 Jun; 498(7455):521-5. PubMed ID: 23739335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Study of HCV p7 Channel: Insight into a New Strategy for HCV Inhibitor Design.
    Ying B; Pang S; Yang J; Zhong Y; Wang J
    Interdiscip Sci; 2019 Jun; 11(2):292-299. PubMed ID: 30194627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional structure and interaction studies of hepatitis C virus p7 in 1,2-dihexanoyl-sn-glycero-3-phosphocholine by solution nuclear magnetic resonance.
    Cook GA; Dawson LA; Tian Y; Opella SJ
    Biochemistry; 2013 Aug; 52(31):5295-303. PubMed ID: 23841474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pore-forming activity of pestivirus p7 in a minimal model system supports genus-specific viroporin function.
    Largo E; Gladue DP; Huarte N; Borca MV; Nieva JL
    Antiviral Res; 2014 Jan; 101():30-6. PubMed ID: 24189547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR structure and ion channel activity of the p7 protein from hepatitis C virus.
    Montserret R; Saint N; Vanbelle C; Salvay AG; Simorre JP; Ebel C; Sapay N; Renisio JG; Böckmann A; Steinmann E; Pietschmann T; Dubuisson J; Chipot C; Penin F
    J Biol Chem; 2010 Oct; 285(41):31446-61. PubMed ID: 20667830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.
    Walter S; Bollenbach A; Doerrbecker J; Pfaender S; Brown RJP; Vieyres G; Scott C; Foster R; Kumar A; Zitzmann N; Griffin S; Penin F; Pietschmann T; Steinmann E
    J Virol; 2016 May; 90(10):5075-5089. PubMed ID: 26962224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.
    Hong W; Lang Y; Li T; Zeng Z; Song Y; Wu Y; Li W; Cao Z
    J Biol Chem; 2015 Sep; 290(38):23254-63. PubMed ID: 26251517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
    Griffin S; Stgelais C; Owsianka AM; Patel AH; Rowlands D; Harris M
    Hepatology; 2008 Dec; 48(6):1779-90. PubMed ID: 18828153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
    Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
    Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?
    Griffin S
    Future Med Chem; 2014; 6(17):1893-907. PubMed ID: 25495983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
    Breitinger U; Farag NS; Ali NKM; Ahmed M; El-Azizi MA; Breitinger HG
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33709903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.
    Denolly S; Mialon C; Bourlet T; Amirache F; Penin F; Lindenbach B; Boson B; Cosset FL
    PLoS Pathog; 2017 Dec; 13(12):e1006774. PubMed ID: 29253880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.